Prostate Cancer: What you need to know about the disease now

Last Updated on 30/01/2023 by Steve Wanjie

I. Introduction to Prostate cancer

“Prostate cancer is a severe disease that affects many men.

This article discusses the risk factors, symptoms, diagnosis, treatment options, and prevention strategies for prostate cancer.

In addition, learn how early detection and treatment can lead to successful outcomes.”

A brief overview of prostate cancer

The prostate, a little organ found beneath the bladder in males, is where prostate cancer typically originates.

It is the most prevalent malignancy in American males and the second-leading cause of cancer death in men.

A tumor forms in the prostate when the cells increase and expand uncontrolled.

Cancer can spread to other organs and tissues, including lymph nodes and bones, if not treated.

Prostate cancer may not show any signs in some men.

Others, on the other hand, can struggle to urinate, urinate painfully, have blood in their urine or menstrual blood, have erectile dysfunction, or have bone discomfort.

Early detection and treatment are, therefore, essential for a positive result.

Statistics on incidence and mortality rates

The American Cancer Society estimates that in 2021, there were 191,930 new cases of prostate cancer identified in the US, and 33,330 men died from the condition.

After skin cancer, prostate cancer is the second most frequent cancer in men in the US.

The likelihood of developing the disease rises with age, with males over 65 receiving most diagnoses.

Distinct ethnic groups have different prostate cancer incidence rates. African American and Caribbean men of African heritage are more likely to get prostate cancer than men of other races.

Additionally, men with a family history of the condition are more likely to get it.

The mortality rate for prostate cancer has decreased in recent years due to advances in screening and treatment.

However, prostate cancer is still the second leading cause of cancer death among men in the United States, behind lung cancer.

It is important to note that these statistics are estimates and are subject to change based on new research and data.

II. The four prostate cancer risk factors

a) Prostate cancer risk factor 1: Age

Age is a significant risk factor for prostate cancer.

The risk of developing the disease increases as men get older.

Prostate cancer is most commonly diagnosed in men over the age of 65.

Most prostate cancer cases are found in men between the ages of 65 and 74.

The risk of developing prostate cancer increases with age, and men over 75 are at the highest risk.

As men age, their prostate gland tends to enlarge, a condition called benign prostatic hyperplasia (BPH).

It can make it difficult for the doctor to examine the prostate during a digital rectal exam (DRE) or for the patient to urinate.

This can make it harder to detect prostate cancer at an early stage.

Regular screening for prostate cancer is recommended for men over the age of 50 and for men who are at higher risk, such as African American men and men with a family history of the disease.

b) Prostate cancer risk factor 2: Family history

A family history of prostate cancer is a known risk factor for developing the disease.

Men with a father or brother diagnosed with prostate cancer are more likely to develop the disease themselves.

The risk is even greater if the family member was diagnosed at a young age.

A family history of prostate cancer may indicate the presence of genetic mutations that increase the risk of developing the disease.

Men with a family history of prostate cancer should discuss their risk with their healthcare provider and consider starting screenings earlier.

Men with a family history of prostate cancer should also be aware of other risk factors for the disease, such as age, ethnicity, diet, and lifestyle factors.

In addition, some genetic disorders, such as Lynch syndrome and HPC1, are associated with an increased risk of prostate cancer.

It’s important to note that many men who develop prostate cancer do not have a family history of the disease.

While family history is a risk factor, it is not the only one.

Many men without a family history will still be diagnosed with prostate cancer.

c) Prostate cancer risk factor 3: Ethnicity

Ethnicity is also a known risk factor for prostate cancer.

Studies have shown that certain ethnic groups have a higher incidence of prostate cancer than others.

For example, African American men and Caribbean men of African descent have the highest incidence of prostate cancer, followed by men of North American, European, and Asian descent.

The reason for the higher incidence of prostate cancer among African American men and Caribbean men of African descent is not fully understood.

Still, it may be due to genetic, environmental, and lifestyle factors.

For example, African American men are more likely to have a family history of prostate cancer and to be diagnosed earlier.

They also have higher levels of prostate-specific antigen (PSA).

They are more likely to have more aggressive forms of the disease.

Men of all ethnicities must be aware of their risk for prostate cancer and discuss screening options with their healthcare provider.

Regular screenings and early detection can lead to successful outcomes, regardless of ethnicity.

Prostate cancer risk factor 4: Diet and lifestyle factors

Diet and lifestyle factors may also play a role in the development of prostate cancer.

Studies have shown that certain dietary and lifestyle habits may increase the risk of developing the disease.

A diet high in red meat, processed meats, and dairy products and low in fruits and vegetables has been linked to an increased risk of prostate cancer.

In addition, men who consume a diet high in saturated and trans fats and omega-3 fatty acids may also have a higher risk of prostate cancer.

Obesity is also a risk factor for prostate cancer.

Men who are overweight or obese have a higher risk of developing the disease, and their cancer is more likely to be advanced or aggressive.

Smoking and excessive alcohol consumption are also associated with an increased risk of prostate cancer.

Men who smoke or consume alcohol excessively have a higher risk of developing the disease, and their cancer is more likely to be advanced or aggressive.

A lack of physical activity is also associated with a higher risk of prostate cancer and other chronic diseases.

It’s important to note that while these factors can increase the risk of prostate cancer, they do not necessarily cause the disease.

Also, it’s essential to consider that multiple risk factors can interact and contribute to the development of prostate cancer, and it’s not a one-dimensional issue.

III. Prostate cancer symptoms

Prostate cancer symptom number 1: Difficulty urinating

Difficulty urinating is a common symptom of prostate cancer. As the tumor grows, it can press against the urethra, the tube that carries urine out of the body. This can cause a variety of urinary symptoms, including:

• Difficulty starting to urinate
• Weak or interrupted urine flow
• A feeling of incomplete bladder emptying
• Frequent urination, especially at night
• Pain or burning during urination

It’s important to note that these symptoms can also be caused by other conditions, such as an enlarged prostate (benign prostatic hyperplasia) or a urinary tract infection.

However, suppose these symptoms persist or are accompanied by blood in the urine or pain in the lower back, hips, or pelvic area.

In that case, speaking with a healthcare provider is crucial to rule out prostate cancer.

Prostate cancer can be diagnosed by combining the digital rectal exam (DRE), PSA test, and biopsy.

If prostate cancer is diagnosed, the treatment options available depending on the stage and grade of cancer and the patient’s overall health.

However, early detection and treatment can lead to better outcomes and a higher chance of survival.

Prostate cancer symptom number 2: Painful urination

Painful urination, also known as dysuria, can be a symptom of prostate cancer.

As the tumor grows, it can press against the urethra.

This tube carries urine out of the body, causing irritation and inflammation, which leads to pain.

This pain can be felt in the lower abdomen, penis, or scrotum and can range from mild discomfort to severe pain.

It’s important to note that painful urination can also be caused by other conditions, such as urinary tract infections, bladder infections, kidney stones, or sexually transmitted infections.

However, suppose the pain persists or is accompanied by other symptoms, such as blood in the urine or difficulty urinating.

In that case, speaking with a healthcare provider to rule out prostate cancer is essential.

Prostate cancer can be diagnosed by combining the digital rectal exam (DRE), PSA test, and biopsy.

If prostate cancer is diagnosed, the treatment options available depending on the stage and grade of cancer and the patient’s overall health.

However, early detection and treatment can lead to better outcomes and a higher chance of survival.

Prostate cancer symptom number 3: Blood in urine or semen

Blood in the urine or semen is a possible symptom of prostate cancer.

The presence of blood in urine or semen is also known as hematuria or hematospermia.

The cancerous cells can irritate or damage the prostate or surrounding structures, leading to bleeding and blood in the urine or semen.

However, it’s important to note that other conditions, such as urinary tract infections, kidney stones, or prostate or urinary tract injury, can also cause this symptom.

It is crucial to speak with a healthcare provider if you notice any blood in your urine or semen, as it could signify a more severe condition.

The healthcare provider will perform a physical examination, including a digital rectal exam (DRE), and may also order blood and urine tests, imaging studies, and a biopsy.

Prostate cancer can be diagnosed by combining the digital rectal exam (DRE), PSA test, and biopsy.

If prostate cancer is diagnosed, the treatment options available depending on the stage and grade of cancer and the patient’s overall health.

However, early detection and treatment can lead to better outcomes and a higher chance of survival.

Prostate cancer symptom number 4: Erectile dysfunction

Erectile dysfunction (ED), also known as impotence, is the inability to achieve or maintain an erection sufficient for sexual intercourse.

This can be a symptom of prostate cancer.

As the tumor grows, it can press against the nerves and blood vessels responsible for achieving and maintaining an erection.

This can cause erectile dysfunction.

It’s important to note that erectile dysfunction can also be caused by other conditions such as diabetes, hypertension, high cholesterol, or psychological issues.

However, suppose erectile dysfunction persists or is accompanied by other symptoms such as difficulty urinating, blood in the urine or semen, or pain in the lower back, hips, or pelvic area.

In that case, speaking with a healthcare provider to rule out prostate cancer is essential.

Prostate cancer can be diagnosed by combining the digital rectal exam (DRE), PSA test, and biopsy.

If prostate cancer is diagnosed, the treatment options available depending on the stage and grade of cancer and the patient’s overall health.

However, early detection and treatment can lead to better outcomes and a higher chance of survival.

Prostate cancer symptom number 5: Bone pain

Bone pain is a possible symptom of prostate cancer.

Prostate cancer can spread (metastasize) to other body parts, including the bones, which can cause pain.

The bones most commonly affected by prostate cancer include the pelvis, hips, spine, and legs.

The pain can be a dull, aching sensation or can be sharp and severe.

Other symptoms associated with bone metastasis may include fatigue, weakness, weight loss, and a loss of appetite.

It’s important to note that other conditions, such as osteoporosis, arthritis, or injury, can cause bone pain.

However, suppose the pain persists or is accompanied by other symptoms such as difficulty urinating, blood in the urine or semen, or pain in the lower back, hips, or pelvic area.

In that case, speaking with a healthcare provider is crucial to rule out prostate cancer.

Prostate cancer can be diagnosed by combining the digital rectal exam (DRE), PSA test, and biopsy.

If prostate cancer is diagnosed, the treatment options available depending on the stage and grade of cancer and the patient’s overall health.

However, early detection and treatment can lead to better outcomes and a higher chance of survival.

IV. How to diagnose prostate cancer

a) Prostate cancer diagnosis number 1: Digital rectal exam

A digital rectal exam (DRE) is a diagnostic tool used to assess the prostate gland for signs of cancer or other abnormalities.

During a DRE, a healthcare provider will insert a gloved finger into the rectum to feel the prostate.

The prostate is located just below the bladder and in front of the rectum and can be felt through the rectal wall.

In addition, the healthcare provider will feel for any lumps or irregularities on the surface of the prostate, which may indicate the presence of cancer.

A DRE is typically performed with a blood test called a prostate-specific antigen (PSA).

The PSA test measures the level of PSA in the blood. PSA is a protein produced by the prostate, and high levels of PSA can indicate the presence of cancer.

However, elevated PSA levels can also be caused by other conditions, such as an enlarged prostate or infection.

If the DRE and PSA test results suggest the presence of cancer, a prostate biopsy will be performed.

During a biopsy, a small sample of tissue is taken from the prostate and examined under a microscope to confirm the presence of cancer cells.

It’s important to note that a DRE alone is not considered sufficient for a definitive diagnosis of prostate cancer.

The DRE results should be considered in conjunction with the results of other diagnostic tests, such as the PSA test and biopsy.

Prostate cancer diagnosis number 2: Prostate-specific antigen (PSA) test

The prostate-specific antigen (PSA) test is a blood test that measures the level of PSA in the blood.

PSA is a protein produced by the prostate, and high levels of PSA can indicate the presence of cancer.

However, elevated PSA levels can also be caused by other conditions, such as an enlarged prostate or infection.

The PSA test is typically performed with a digital rectal exam (DRE).

The DRE is a diagnostic tool used to assess the prostate gland for signs of cancer or other abnormalities.

During a DRE, a healthcare provider will insert a gloved finger into the rectum to feel the prostate.

The prostate is located just below the bladder and in front of the rectum and can be felt through the rectal wall.

In addition, the healthcare provider will feel for any lumps or irregularities on the surface of the prostate, which may indicate the presence of cancer.

If the PSA test and DRE results suggest the presence of cancer, a prostate biopsy will be performed.

During a biopsy, a small sample of tissue is taken from the prostate and examined under a microscope to confirm the presence of cancer cells.

It’s important to note that the PSA test alone is not considered sufficient for a definitive diagnosis of prostate cancer.

The PSA test results should be considered in conjunction with the results of other diagnostic tests such as DRE and biopsy.

Also, the PSA test can have false positives and negatives, so combining different diagnostic tests is essential.

Finally, the results should be interpreted by a healthcare professional who is an expert in prostate cancer diagnosis.

Prostate cancer diagnosis number 3: Biopsy

A biopsy is a diagnostic procedure that involves removing a small sample of tissue from the prostate for examination under a microscope.

A biopsy is typically performed to confirm the presence of cancer or other abnormalities in the prostate.

There are different ways to perform a prostate biopsy.

Still, the most common method is the transrectal ultrasound (TRUS) guided biopsy. During a TRUS biopsy, a tiny probe is inserted into the rectum and used to drive a needle through the rectal wall to remove small tissue samples from the prostate. The procedure is usually done under local anesthesia and takes about 15-20 minutes.

Other types of biopsy include the transperineal biopsy, where the needle is inserted through the skin between the scrotum and the anus, and the MRI-guided biopsy, where the MRI scan is used to guide the needle to the suspicious area.

It’s important to note that a biopsy is considered the most definitive way to diagnose prostate cancer, and the biopsy results are used to determine the stage and grade of the tumor.

However, it’s important to understand that a biopsy may not detect all prostate cancer cases.

Therefore, the biopsy results should be interpreted by a healthcare professional who is an expert in prostate cancer diagnosis.

It’s also important to note that a biopsy may cause some temporary side effects, such as pain, bleeding, and discomfort. Still, these side effects typically resolve within a few days.

V. Prostate cancer treatment options

Prostate cancer diagnosis number 1: Surgery (prostatectomy)

Prostatectomy is a surgical procedure to remove the prostate gland.

Different types of prostatectomy can be performed, depending on the stage and grade of cancer.

The most common type of prostatectomy is radical prostatectomy, which involves the removal of the entire prostate gland and some surrounding tissue and lymph nodes.

Radical prostatectomy can be performed through an open incision (open prostatectomy) or using laparoscopic instruments (laparoscopic prostatectomy).

Another surgical option is the robotic-assisted laparoscopic prostatectomy, where the procedure is performed with the help of a robot.

This procedure allows the surgeon to visualize the prostate and surrounding tissue better.

In addition, it’s associated with less blood loss and shorter recovery times compared to open prostatectomy.

Radical prostatectomy is typically recommended for men with early-stage prostate cancer who are otherwise healthy and have a life expectancy of at least 10-15 years.

However, it’s important to note that the surgery can cause some side effects, such as incontinence and erectile dysfunction.

Still, these side effects can be temporary or permanent.

In addition, the risk of complications varies depending on the technique used and the patient’s condition.

Prostatectomy is a significant surgery, and patients should have a complete discussion with their surgeon and a urologist to understand the risks and benefits of the procedure.

Prostate cancer treatment number 2: Radiation therapy

Radiation therapy, also known as radiotherapy, is a treatment option for prostate cancer that uses high-energy radiation to destroy cancer cells.

Different types of radiation therapy can be used to treat prostate cancer, including external beam radiation therapy (EBRT) and brachytherapy.

External beam radiation therapy (EBRT) is the most common radiation therapy used to treat prostate cancer.

It involves the use of a machine called a linear accelerator that delivers high-energy radiation beams to the prostate from outside the body.

EBRT is usually given as a series of treatments, typically five treatments per week for several weeks.

Brachytherapy is another radiation therapy involving placing tiny radioactive seeds directly into the prostate.

The sources give off a low level of radiation over time and are left in the prostate permanently.

Brachytherapy can be done as a low-dose rate (LDR) or high-dose-rate (HDR) procedure.

Radiation therapy can be an effective treatment option for prostate cancer and is usually recommended for men with early-stage cancer or those not candidates for surgery.

Side effects of radiation therapy can include fatigue, skin irritation, and bowel and bladder problems.

However, most side effects are temporary and can be managed with medication.

In addition, long-term side effects such as impotence and incontinence are less familiar with current techniques.

It’s important to note that radiation therapy can be used alone or in combination with other treatments, such as surgery or hormone therapy.

The choice of treatment will depend on the stage and grade of cancer, the patient’s overall health and preferences, and the expertise of the treating team.

Prostate cancer treatment number 3: Hormone therapy

Hormone therapy, also known as androgen deprivation therapy (ADT), is a treatment option for prostate cancer that lowers the levels of male hormones called androgens, which can fuel the growth of prostate cancer cells.

There are several different ways to lower androgen levels, including:

Luteinizing hormone-releasing hormone (LHRH) agonists:

These drugs work by inhibiting the release of the luteinizing hormone (LH), which stimulates testosterone production.

Standard LHRH agonists include leuprolide, goserelin, and triptorelin.

Orchiectomy is a surgical procedure to remove one or both testicles, the primary source of testosterone in the body.

Anti-androgens:

These drugs block the effects of androgens on prostate cancer cells. Common anti-androgens include bicalutamide, flutamide, and nilutamide.

Hormone therapy is typically recommended for men with advanced prostate cancer that has spread beyond the prostate or for those with a high risk of recurrence after surgery.

Hormone therapy can slow the growth of prostate cancer cells and relieve symptoms such as bone pain, but it does not cure cancer.

Side effects of hormone therapy can include hot flashes, decreased libido, breast enlargement, osteoporosis,s and fatigue.

Long-term hormone therapy can also increase the risk of heart disease, diabetes, and cognitive decline.

It’s important to note that hormone therapy can be used alone or in combination with other treatments, such as radiation therapy or chemotherapy.

The choice of treatment will depend on the stage and grade of cancer, the patient’s overall health and preferences, and the expertise of the treating team.

Prostate cancer treatment number 4: Chemotherapy

Chemotherapy is a treatment option for prostate cancer that uses drugs to kill cancer cells.

Chemotherapy is usually recommended for men with advanced prostate cancer that has spread beyond the prostate and is less commonly used to treat early-stage prostate cancer.

The most commonly used chemotherapy drugs for prostate cancer are docetaxel and cabazitaxel, which are given intravenously in a cycle of treatment followed by a rest period.

Some other chemotherapy drugs that may be used for prostate cancer include estramustine, mitoxantrone, and cisplatin.

Chemotherapy can effectively slow the growth of prostate cancer cells and relieve symptoms, but it does not cure cancer.

In addition, the side effects of chemotherapy can include hair loss, nausea, vomiting, diarrhea, anemia, and fatigue.

Still, these side effects are usually temporary and can be managed with medication.

It’s important to note that chemotherapy is usually used with other treatments, such as hormone therapy.

The choice of treatment will depend on the stage and grade of cancer, the patient’s overall health and preferences, and the expertise of the treating team.

Chemotherapy can have serious side effects, such as anemia, fatigue, nausea, vomiting, and decreased white blood cells, which can increase the risk of infection.

Therefore, it’s essential for patients receiving chemotherapy to be closely monitored by their doctor.

Prostate cancer treatment number 5: Active surveillance

Active surveillance is a treatment option for men with early-stage prostate cancer that is considered low-risk.

The goal of active surveillance is to monitor cancer closely and only intervene with treatment if cancer begins to grow or spread.

Active surveillance typically involves regular visits to a doctor for a digital rectal exam, prostate-specific antigen (PSA) test, and sometimes a biopsy.

In addition, imaging tests such as a prostate MRI may also be used to monitor cancer.

If cancer begins to grow or spread, treatment options such as surgery, radiation therapy, or hormone therapy may be recommended.

Active surveillance is a good option for men with a low risk of prostate cancer progression or a high risk of complications from surgery or other treatments.

It’s important to note that active surveillance is unsuitable for all men with prostate cancer.

Therefore, it is essential to discuss the best treatment option with a urologist or an oncologist familiar with prostate cancer and consider the patient’s overall health and preferences.

Active surveillance can be beneficial in avoiding unnecessary treatments and their side effects; it’s also vital to ensure that the cancer is not progressing, which requires regular monitoring, biopsies, and follow-up visits.

Prostate cancer treatment number 6: supplements

Supplements are not a standard treatment option for prostate cancer, and it’s important to note that the effectiveness of supplements in treating prostate cancer has not been proven through clinical research.

Several supplements are commonly used by people with prostate cancer, including:

Saw palmetto: a herb that is believed to help with symptoms of an enlarged prostate

Omega-3 fatty acids: found in fish oil, these are believed to have anti-inflammatory properties

Vitamin D: some studies have suggested that a deficiency in vitamin D may be associated with an increased risk of prostate cancer

Selenium: an antioxidant that may help to protect cells from damage

Green tea: contains compounds called catechins that have antioxidant properties.

ProstatRelax Capsules:

ProstatRelax Capsules is the most advanced health supplement that helps treat prostate issues without side effects.

ProstatRelax Capsules benefits:

• Prevents prostate enlargement.

• Shrinks an enlarged prostate gland.

• Reduces urinary symptoms such as frequent urination, urinary urgency, and urinary dribbling.

• Helps maintain a healthy prostate.

• Suitable for impotence and sexual dysfunction.

• Helps alleviate pain or stiffness in the lower back, hip, or upper thighs.

• Helps enhance sexual performance.

It’s important to note that taking supplements can have side effects and may interact with other medications.

Therefore, it’s essential to consult with a healthcare provider before taking any supplements, especially if you’re receiving any other treatment for prostate cancer.

Additionally, it’s important to note that most studies on supplements and prostate cancer are inconclusive.

More research is needed before drawing any definite conclusions.

Therefore, it’s not recommended to rely on supplements as the sole treatment for prostate cancer.

VI. Prostate cancer Prevention Measures

Prostate cancer prevention measure 1: Healthy diet and exercise

A healthy diet and regular exercise may help to reduce the risk of developing prostate cancer.

A diet high in fruits, vegetables, and whole grains and low in red meat, processed foods, and saturated fats may help reduce the risk of developing prostate cancer.

In addition, eating a diet that is high in calcium and vitamin D may also be beneficial.

Regular exercises, such as brisk walking or cycling, have been shown to lower the risk of developing prostate cancer.

Therefore, aiming for at least 30 minutes of moderate-intensity physical activity most days of the week is recommended.

Maintaining a healthy weight is also essential, as being overweight or obese has been linked to an increased risk of prostate cancer.

Additionally, it’s important to note that there is no definitive evidence that a specific diet or exercise regimen can prevent prostate cancer, but living a healthy lifestyle can have many other benefits, such as reducing the risk of other chronic diseases.

It’s essential to consult with a healthcare provider before making any significant changes to your diet or exercise routine, especially if you have a history of prostate cancer in your family or if you have any other health concerns.

 Prostate cancer Prevention measure 2: Avoiding exposure to toxins

Avoiding exposure to toxins may help to reduce the risk of developing prostate cancer.

Some studies suggest that exposure to certain chemicals and toxins may increase the risk of prostate cancer.

These include:

• Pesticides: exposure to pesticides, particularly organochlorine pesticides, have been linked to an increased risk of prostate cancer.
• Heavy metals: exposure to heavy metals, such as cadmium and lead, has been linked to an increased risk of prostate cancer.
• Industrial chemicals: exposure to certain industrial chemicals, such as polycyclic aromatic hydrocarbons (PAHs) and polychlorinated biphenyls (PCBs), has been linked to an increased risk of prostate cancer.

It’s important to note that more research is needed to confirm the link between exposure to toxins and the development of prostate cancer.

Additionally, it’s important to remember that most people are exposed to small amounts of toxins daily, so avoiding exposure is not always possible.

However, some steps can be taken to reduce exposure to toxins:

• Eating organic foods can help to avoid exposure to pesticides.
• Avoiding smoking and secondhand smoke can help to reduce exposure to certain toxins.
• Preventing exposure to certain industrial chemicals, such as solvents and certain types of paint.
• Filtering your water can also be a way to reduce exposure to certain toxins.

It’s essential to consult with a healthcare provider before taking any steps to reduce exposure to toxins, especially if you have a history of prostate cancer in your family or if you have any other health concerns.

Prostate cancer Prevention measure 3: Regular screenings

 Regular screenings may help detect prostate cancer early, improving the chances of successful treatment.

The American Cancer Society recommends that men discuss with their healthcare provider the pros and cons of prostate cancer screening, starting at age 50.

Men at higher risk (African American men or men with a family history of prostate cancer) should start this conversation at age 45.

The most common screening tests for prostate cancer are the digital rectal exam (DRE) and the prostate-specific antigen (PSA) test.

The DRE involves a healthcare provider checking for any abnormalities in the prostate by feeling the gland through the rectum.

The PSA test measures the level of PSA, a protein produced by the prostate, in a man’s blood.

Elevated PSA levels can indicate the presence of prostate cancer.

It’s important to note that these tests can have false-positive results and lead to unnecessary procedures.

Therefore, it’s essential to converse with your healthcare provider to weigh the benefits and potential harms of screening and make an informed decision.

Other factors such as symptoms, family history, and overall health should also be considered when deciding whether to undergo screening.

It’s essential to consult with a healthcare provider before undergoing any screening test, especially if you have a history of prostate cancer in your family or if you have any other health concerns.

Conclusion:

 Prostate cancer is a severe disease, but early detection and treatment can lead to successful outcomes.

It is crucial for men to be aware of their risk factors and to discuss screening options with their healthcare providers.

Men need to reduce their risk of prostate cancer by maintaining a healthy diet and exercise, avoiding exposure to toxins, and undergoing regular screenings.

While prostate cancer can cause severe symptoms and complications, it is usually slow-growing.

As a result, many men with the disease will never experience symptoms or require treatment.

Active surveillance is a treatment option for men with low-risk prostate cancer, which allows them to closely monitor cancer without immediately undergoing treatment.

In conclusion, prostate cancer is a severe disease.

Still, many men can successfully manage and overcome it with early detection and effective treatment options.

Men must be proactive in their health and work closely with their healthcare providers to ensure the best possible outcome.

Prostate cancer treatment using BF Suma supplements

Prostate cancer causes

Home